SCHEMBL8016038

SCHEMBL8016038

O=C(Cc1ccccc1)N(C(=O)c1ccc2ccccc2c1)c1cc[c]cc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.43
ESR2 Q92731 1/20 0.43
ACHE P22303 2/20 0.42
NR1H4 Q96RI1 2/20 0.41
PLAU P00749 1/20 0.41
GPR52 Q9Y2T5 1/20 0.40
CES2 O00748 1/20 0.40
CES1 P23141 1/20 0.40
MAPK14 Q16539 1/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PTPN1 P18031 1/20 0.38
NPC1 O15118 1/20 0.38
PTGES O14684 1/20 0.38
ALOX5 P09917 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8001529 0.85 REN (0.43) CES2CES1NPC1ALOX5
SCHEMBL8013217 0.85 ESR1 (0.46) ESR1ESR2ACHENR1H4PLAU
SCHEMBL8012102 0.84 ESR1 (0.49) ESR1ESR2ACHEPLAUCES2
SCHEMBL8010344 0.82 SMN1; SMN2 (0.43) ESR1ESR2CES2CES1KDM4E
SCHEMBL8012822 0.81 CES1 (0.45) CES2CES1ALOX5
SCHEMBL10588465 0.76 ESR1 (0.49) ESR1ESR2ACHEPLAUCES2
SCHEMBL8010740 0.76 CRHBP (0.43) CES2CES1LMNANPC1ALOX5
SCHEMBL8013246 0.72 TP53 (0.45) CES2CES1NPC1ALOX5
SCHEMBL8012938 0.71 ALOX5 (0.52) GAASMN1; SMN2NPC1ALOX5
SCHEMBL8009229 0.71 NPC1 (0.57) NR1H4GAAHTTSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1066729-C Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-06-06 CN disclosed
CN-1060173-C Heterocyclic compound with activity against diabetes and preparation and application of same MITSUTAKA CO LTD (JP) 2001-01-03 CN disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 US disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 US disclosed
CN-1157288-A Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1997-08-20 CN disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 US disclosed
CN-1118781-A Heterocyclic compound with activity against diabetes and preparation and application of same MITSUTAKA CO LTD (JP) 1996-03-20 CN disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 EP disclosed